Table 2

Proportions of oropharyngeal test results after regular treatment at weeks 4, 8 and 12 by the preceding week 0 (enrolment, just prior to treatment) test result, FemCure

Week 0 (enrolment, pretreatment)#	Tested at week 4	Week 4: PhCT−	Week 4: PhCT+	Tested at week 8	Week 8: PhCT−	Week 8: PhCT+	Tested at week 12	Week 12: PhCT−	Week 12: PhCT+
Week 0 (enrolment, pretreatment)#	N	n (%)	n (%)	N	n (%)	n (%)	N	n (%)	n (%)
Total	449	446 (99.3)	3 (0.7)a	433	431 (99.5)	2 (0.5)a	427	420 (98.4)	7 (1.6)b
PhCT− (n=514)	413	411 (99.5)	2 (0.5)a	397	396 (99.5)	1 (0.5)a	391	386 (98.7)	5 (1.3)c
PhCT+ (n=46)	36	35 (97.2)*	1 (2.8)a	36	35 (97.2)	1 (2.8)a	36	34 (94.4)	2 (5.6)c

a: All reported recent (receptive) oral sex.
b: n=5 reported recent (receptive) oral sex.
c: n=1 reported recent (receptive) oral sex.
*Indicates ‘cure’.
CT, Chlamydia trachomatis; Ph, oropharyngeal; PhCT+/−, oropharyngeal positive or negative test result.